SEATTLE — November 2, 2023 — Below is a summary of recent research findings and other news from Fred Hutchinson Cancer Center.
November is Lung Cancer Awareness Month. If you are looking for resources, please see our media tip sheet and contact us at hplatisha@fredhutch.org. To set up an interview.
Do you want to cover it? ASH (American Society of Hematology) Annual Meeting• Sign up for Fred Hutch’s ASH Tip Sheet for Research and Professionals: media@fredhutch.org.
Cancer and nursing care series
November is National Family Caregiver Month, and you’ll be doing everything from taking notes during doctor’s appointments to being there for your loved one during long chemotherapy treatments to caring for them at home as they deal with the side effects of grueling treatments. The spotlight will be expanded to the army of caregivers who do the same. Treatment. The series includes:
Media contact: media@fredhutch.org
Cancer research and treatment
Three new grants power colorectal cancer research
Dr. Jeroen Huyghe. Dr. Ulrike Peters, MPH; Dr. Li Hsu. and Dr. Carolyn Rutter received grants from the National Cancer Institute to study her three different aspects of colorectal cancer. Huyghe will investigate the molecular and cellular profiles of colorectal cancer tumors and immune microenvironments in Alaska Natives. Peters and Hsu will further examine the risk of colorectal cancer, and Rutter will examine the health and economic costs of unequal care in colorectal cancer.
Media contact: cat win kwynn@fredhutch.org
Two women with breast cancer share their perspectives on living with breast cancer
Patients Leah Marcoux and Maria Pearson share their experiences with breast cancer. They not only share what life has been like since their diagnosis and offer advice on how to survive a breast cancer diagnosis and changes in treatment plans, but also share what living with breast cancer has taught them personally. Also talk about how it has affected your life.
Media contact: Heather Pratisha hplatisha@fredhutch.org
Funding American Indian and Alaska Native smoking cessation trials
Behavioral psychologist Dr. Jonathan Bricker received a grant from NCI to conduct a randomized controlled clinical trial of a smoking cessation app designed specifically for Indigenous people. The grant will test the effectiveness of the smartphone app ICanQuit, which was tested by Fred Hutch, and QuitGuide, a digital smoking prevention app provided by NCI.
Media contact: claire hudson crhudson@fredhutch.org
Expanding the efficacy of CAR-T cell therapy
Immunotherapy researcher Dr. Shivani Srivastava is investigating whether genetically engineered CAR (chimeric antigen receptor) T cells have the ability to form self-renewing reservoirs of anti-cancer cells and how to improve CAR T cells. We researched ways to promote its formation and received an NCI MERIT Award. -Cell therapy for solid tumors.
Media contact: Molly McElroy mwmcelro@fredhutch.org
New technology could make precision medicine more widely available
When studying the molecular characteristics of tumors, it is easiest to do so with fresh or frozen cells. However, more often than not, researchers use formalin-fixed, paraffin-embedded, or his FFPE tissue samples.A recently published paper on a new method led by biologist Dr. Steve Henikoff nature communications It could be easier to study older tumor samples and compare them with patient outcomes.
Media contact: Molly McElroy mwmcelro@fredhutch.org
community news
Fred Hutch Announces Eight Recipients of the 2023 Eddie Mendez Doctoral Scholar Awards
Fred Hutch has announced the winners of the 2023 Eddie Mendes Doctoral Scholars Award, which recognizes young scientists from underrepresented groups in science and scientists with disabilities. The eight postdoctoral award winners represent a variety of research institutions across the United States and are experts in a variety of topics, including interactions between tumors and the immune system, cell signaling in obesity, and the relationship between parasites and cancer. be.
Media contact: Molly McElroy mwmcelro@fredhutch.org
Dr. Lawrence Fung appointed director of the Center for Integrated Immunotherapy Research
Fred Hutch announced the hiring of Lawrence Fong, MD, as scientific director of the Center for Integrative Immunotherapy Research. He has been involved in both preclinical and clinical development of multiple immunotherapies, including currently FDA-approved immune checkpoint inhibitors. In 2021, he received the National Cancer Institute Outstanding Investigator Award. This award will give him $4.2 million over his seven years for his projects. Determinants of response to cancer immunotherapy. He is scheduled to assume his new role on July 1, 2024.
Media contact: Molly McElroy mwmcelro@fredhutch.org
BRCA mutation researcher Dr. Rose Valentine Bosile named Brave Fellow
Research by Dr. Rose Valentine Bosile in the laboratory of Richard Adeyemi, DVM, Ph.D. Investigate drug resistance in cancers with mutations in BRCA1 and BRCA2 genes. Bosile is the fourth recipient of the Brave Fellowship, which supports young researchers from underrepresented backgrounds studying rare cancers.
Media contact: cat win kwynn@fredhutch.org
News information via social media
This is a summary of experts’ opinions.If you would like to know more, please contact us media@fredhutch.org
science spotlight
Each month, Science Spotlight publishes articles written by postdoctoral researchers summarizing new research papers by Fred Hutch scientists. If you would like to learn more or would like to discuss any of these topics, please contact us. media@fredhutch.org
# # #
Fred Hutchinson Cancer Center combines personalized care and advanced research to provide the latest cancer treatment options while accelerating discoveries to prevent, treat and cure cancer and infectious diseases worldwide. doing.
Seattle-based Fred Hutch is an independent nonprofit organization and the only National Cancer Institute-designated cancer center in Washington state. The company has a global reputation for discoveries in cancer, infectious diseases and basic research, including important advances in bone marrow transplantation, immunotherapy, HIV/AIDS prevention and COVID-19 vaccines. Fred Hutch operates eight clinical care facilities providing oncology, infusion, radiation, proton therapy and related services. Fred Hutch also runs the cancer program at UW Medicine.